Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3738325019 | Product containing only atenolol and bendroflumethiazide in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3738326018 | Atenolol and bendroflumethiazide only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3738325019 | Product containing only atenolol and bendroflumethiazide in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3738326018 | Atenolol and bendroflumethiazide only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5547761000241114 | produit contenant seulement de l'aténolol et du bendrofluméthiazide sous forme orale | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
5547761000241114 | produit contenant seulement de l'aténolol et du bendrofluméthiazide sous forme orale | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule | Is a | True | Product containing only atenolol and bendroflumethiazide in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier (core metadata concept) |
This concept is not in any reference sets